AS ONE Corporation (TYO:7476)
2,324.00
-19.00 (-0.81%)
At close: Feb 6, 2026
AS ONE Revenue
AS ONE had revenue of 27.79B JPY in the quarter ending December 31, 2025, with 3.92% growth. This brings the company's revenue in the last twelve months to 107.59B, up 5.21% year-over-year. In the fiscal year ending March 31, 2025, AS ONE had annual revenue of 103.75B with 8.60% growth.
Revenue (ttm)
107.59B
Revenue Growth
+5.21%
P/S Ratio
1.54
Revenue / Employee
147.18M
Employees
731
Market Cap
165.62B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 103.75B | 8.22B | 8.60% |
| Mar 31, 2024 | 95.54B | 4.12B | 4.50% |
| Mar 31, 2023 | 91.42B | 4.47B | 5.14% |
| Mar 31, 2022 | 86.95B | 5.35B | 6.55% |
| Mar 31, 2021 | 81.61B | 11.22B | 15.94% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Takeda Pharmaceutical Company | 4.46T |
| Daiichi Sankyo Company | 2.05T |
| Chugai Pharmaceutical | 1.26T |
| HOYA Corporation | 915.21B |
| Towa Pharmaceutical | 266.67B |
| H.U. Group Holdings | 247.43B |
| Kaken Pharmaceutical | 82.02B |
| Nakanishi | 79.17B |
AS ONE News
- 8 months ago - Hong Kong pro-democracy business hit with ‘unwarranted’ tax demand, owner says - Hong Kong Free Press